Artiva Biotherapeutics issues 288,800 RSUs to 17 new hires under inducement plan

• Artiva Biotherapeutics issued inducement grants totaling 288,800 restricted stock units to 17 new employees, effective July 14, 2026.
• Awards were made under the 2025 Inducement Plan.
• Vesting runs four years; 25% vests on the quarterly date nearest the first anniversary of each start date.
• Remaining units vest 1/12 per quarter on subsequent quarterly vesting dates, subject to continued employment.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Artiva Biotherapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607170730PRIMZONEFULLFEED9763840) on July 17, 2026, and is solely responsible for the information contained therein.